Poly-L-lactic acid (PLLA) in arm contouring: a prospective and blinded trial of Rennova® Elleva and Sculptra®.
이 페이지는 아래 학술 논문의 초록(Abstract) 전문을 제공합니다. 원문은 하단 링크에서 확인하세요. ◆ 논문 초록 (Abstract) BACKGROUND: Poly-L-lactic acid (PLLA) is a biostimulatory filler used to improve dermal laxity and contour, yet...
이 페이지는 아래 학술 논문의 초록(Abstract) 전문을 제공합니다. 원문은 하단 링크에서 확인하세요.
◆ 논문 초록 (Abstract)
BACKGROUND: Poly-L-lactic acid (PLLA) is a biostimulatory filler used to improve dermal laxity and contour, yet comparative data between formulations for upper-arm rejuvenation remain scarce. METHODS: In this prospective, randomized, blinded split-arm trial, 20 adults received bilateral upper-arm injections with two PLLA formulations (Rennova® Elleva vs. Sculptra®). Outcomes included Subject and Physician Global Aesthetic Improvement Scales (S-GAIS, P-GAIS), ultrasonography (USG), skin elasticity, and transepidermal water loss (TEWL) through Day 120. Histological analyses in ten cases assessed skin thickness, inflammation, and crystalline residues. RESULTS: Both products yielded marked enhancements in skin texture and arm contour with excellent tolerability. S-GAIS scores improved to 2.9 ± 0.67 at Day 120, with no differences between formulations (p > 0.99). P-GAIS scores similarly rose (Rennova® Elleva: 3.2 ± 0.98; Sculptra®: 3.3 ± 0.90; p = 0.86). Ultrasound findings confirmed dermal remodeling in both arms. By Day 120, USG value increased to 957 ± 209 with Rennova® Elleva (p = 0.049) and 938 ± 174 with Sculptra® (p = 0.92), with no between-group difference (p = 0.99). Skin elasticity increased significantly in both arms by Day 90 (Rennova® Elleva: 172 ± 35 to 191 ± 29, p = 0.035; Sculptra®: 165 ± 19 to 177 ± 24, p = 0.041), while TEWL remained stable. Skin thickness rose significantly (Rennova® Elleva: 2.06 ± 0.55 to 2.66 ± 0.53 mm, p = 0.039; Sculptra®: 1.80 ± 0.41 to 2.70 ± 0.69 mm, p = 0.0039), without between-group differences (p = 0.54). Histology showed sparse perivascular lymphocytes and occasional macrophages, with no granulomas or crystalline material. CONCLUSIONS: This study suggests that both Rennova® Elleva and Sculptra® are effective, well-tolerated PLLA formulations that may be capable of producing meaningful aesthetic and biophysical improvements in upper-arm contour and skin quality within the first 120 days.
◆ 원문 정보
저널: Front Surg
연도: 2026


